GPGI, Inc. Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, executive compensation, and auditor ratification. All proposals passed, including annual advisory votes on compensation and the appointment of Ernst & Young as auditor for 2026.
-
Stockholders approved the proposal to reincorporate from Delaware to Nevada, with a quorum confirmed and voting conducted electronically. Final results will be reported on Form 8-K within four business days.
-
CompoSecure delivered record growth and margin expansion, while Husky faced significant headwinds from resin price spikes, tariffs, and geopolitical disruptions, leading to order delays and margin compression. Revised guidance reflects these challenges, but both businesses remain well-positioned for recovery.
-
Panelists emphasized resilient economic conditions, the importance of hands-on leadership, and a disciplined, growth-focused investment model. Their strategy leverages permanent capital and operational expertise to acquire and scale high-quality businesses, aiming for sustained outperformance and broad industry reach.
Fiscal Year 2025
-
GPGI reported strong FY2025 results, with CompoSecure and Husky both delivering sales growth and operational improvements. FY2026 guidance calls for 8.5% net sales growth and 17% adjusted EBITDA growth, with margin expansion expected as operational initiatives mature.
-
Q3 saw 13% net sales growth and a 30% EBITDA increase, with gross margin rising to 59%. Guidance for 2025 and 2026 was raised, and a $5B Husky Technologies acquisition was announced, expected to be highly accretive and to diversify revenue.
-
Q2 2025 saw 10% net sales growth and 26% EBITDA growth, with margin expansion from operational efficiencies. Full-year guidance was raised, reflecting strong domestic demand, new program launches, and continued investments, while the M&A pipeline remains robust.
-
Q1 2025 net sales were flat at $103.9M, with adjusted EBITDA down 2% and EPS up to $0.25. The company reaffirmed mid-single-digit growth guidance for 2025, citing strong program wins, record Arculus results, and early benefits from operational improvements.
Fiscal Year 2024
-
2024 saw 8% net sales growth, strong free cash flow, and a 60% reduction in net debt. Arculus achieved its first positive net contribution, and the Resolute Holdings spinoff positions the business for further growth and M&A. Guidance calls for mid-single-digit growth in 2025.
-
Q3 2024 saw double-digit net sales and adjusted EBITDA growth, led by international demand and new card programs. Guidance for 2024 was revised upward, with investments in M&A and efficiency initiatives. The Resolute transaction unlocked $20M in annual free cash flow.
-
Q2 net sales hit a record $108.6M, up 10% year-over-year, with adjusted EBITDA up 8% to $40M. A strategic transaction with the David Cote family will simplify share structure and add $20M+ in annual free cash flow. FY2024 guidance was raised to reflect strong domestic and rebounding international growth.